Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic... (c research institutionsand cancer resear...)

Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX

Date:9/4/2007

c research institutions and cancer research centers are scheduled to participate in the study. The Phase II study is anticipated to enroll and evaluate approximately 60 patients over a three-year period. Patients will be evaluated clinically and biopsies will be taken pre- and post-treatment. The biopsies will be analyzed histopathologically, but will also be analyzed for genetic changes using Zila's proprietary LOH assay. The assay is the only validated method for identifying biomarkers consistent with oral premalignencies and oral cancer.

About ViziLite(R) Plus

ViziLite(R) Plus is an oral screening technology that utilizes ViziLite, an advanced chemiluminescent light technology, with Tblue630. The Tblue630 marking system employs Zila Tolonium Chloride (ZTC(TM)), the only patented pharmaceutical-grade form of toluidine blue in an FDA-cleared device.

For more information about ViziLite Plus, visit http://www.vizilite.com.

About Zila's LOH Assay

Biopsies are traditionally analyzed histopathologically to determine the histological changes in diseased tissue and enable classification of the tissue such as benign, dysplastic or cancerous. Leading cancer centers now recognize the value of also evaluating the DNA of biopsy samples for markers that signal that tissue is on the progression pathway to cancer. Zila has developed a proprietary DNA assay that evaluates chromosomal deletions by determining the loss of heterozygosity (LOH) of such biopsies. The validated LOH assay is utilized in the Zila OraTest Phase III clinical trial as well as the Erbitux Study, and the Company is evaluating commercial opportunities for the test.

About Zila, Inc.

Zila, Inc., headquartered in Phoenix, is an oral cancer screening company focused on the prevention and treatment of oral disease. Zila is dedicated to establishing ViziLite(R) Plus as the new standard of care for the early detection of oral
'/>"/>

SOURCE Zila, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Pieris Progresses Proprietary Asthma Program: Validation of Pulmonary Delivery of Anticalin-Based Protein Product Candidate
2. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
3. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
4. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
5. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
6. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
7. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
8. PromegaExpress Expands Easy Access to Products with New Cabinet
9. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
10. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
11. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

Post Your Comments:

(Date:6/19/2013)... , June 19, 2013 Caradigm ... 4.0, a solution designed to help healthcare ... and data while supporting their compliance with ... Provisioning represents a milestone in the delivery ... analytics capabilities for health systems. ...

(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... has recently added DrugPatentWatch to its ... http://www.bharatbook.com/drugpatentwatch-tour.pdf ) (Logo: ... comprehensive information on pharmaceutical, drug patents ... supports the critical business functions of ...

(Date:6/19/2013)... DST Health Solutions, LLC (DSTHS), a leading ... integrated delivery systems, and health care providers, has announced ... (MDMS) has jumped significantly. A customizable ... of medical prescription drug claims, MDMS allows ... drug claims processes. As specialty drug demand grows due ...

Breaking Medicine Technology:Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 2 Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk 3 Drug Patent Watch 2 Drug Patent Watch 3 Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 2 Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase 3

[0] Caradigm Provisioning Helps Healthcare Organizations Improve Clinical Efficiency, Manage Risk [0] Drug Patent Watch [0] Demand For DST's Medical Drug Management Service On The Rise As Health Plan Costs Increase

... to insulin glargine, exenatide offered added benefits of, ... used with metformin --, AMSTERDAM, Netherlands, Sept. ... and Eli Lilly and Company (NYSE: LLY ... injection,with insulin glargine on beta-cell function, glycemic control ...

... Tissue Is Significant for the Treatment of,Cardiovascular Disease, ... Atlantic,University received U.S. patent no. 10/822,496, "Promoting Cardiac ... restores cardiac,muscle function. The invention was discovered by ... F. Lemanski and his postdoctoral fellow,Dr. Chi Zhang. ...

Cached Medicine Technology:One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 2 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 3 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 4 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 5 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 6 One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function 7 FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 2 FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 3 FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function 4

One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function

(Date:6/19/2013)... Texas (PRWEB) June 19, 2013 ... today announced its intent to purchase privately ... Florida, a leader in wheelchair accessible vehicle sales, ... of Auto Mobility Sales, Inc compliments and expands ... wheelchair accessible mobility dealers . The acquisition ...

(Date:6/19/2013)... 2013 The deadline to enter ... Friday, June 21 at midnight ET. This industry-known ... innovative people who’ve raised the bar on magazine ... http://www.minonline.com/ima . , Any consumer and b2b publishing ... eligible to enter. Additionally, advertising agencies and corporations ...

(Date:6/19/2013)... 2013 Strict rules for ... Orriant is launching a new tool to help ... with regulations. New HHS regulations will soon ... if their employer offers outcome-based, health-contingent, compliant wellness ... with these standards for nearly a decade. Orriant ...

(Date:6/19/2013)... 2013 Amber Roberson with the ... LLC, Native Care Health, LLC and Medcase, LLC, ... Underwriters’ (NAHU) new professional development course on the ... continuing education course for agents has been approved ... eleven education credits from the Missouri Department of ...

(Date:6/19/2013)... CA (PRWEB) June 19, 2013 According to ... for Surviving Weekend Sunburn,” it is not uncommon for a ... the summer months. A person is likely to forget to ... , which is both dry and itchy. When this occurs, ... (Go to goo.gl/gDyjP). , “Most people do not realize that ...

Breaking Medicine News(10 mins):Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2 Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2 Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 2 Health News:New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations 3 Health News:RWI Benefits, LLC Becomes PPACA Certified 2 Health News:Skin Care – How to treat Sunburn 2

[0] HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc.[0] Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 [0] New Tool to Increase Participation Rates for Corporate Wellness Programs in July 2013 Will Help Maintain Compliance with Federal Regulations [0] RWI Benefits, LLC Becomes PPACA Certified [0] Skin Care – How to treat Sunburn

... , ... Feb. 11 getSTDtested.com, a physician ... "Kiss Chlamydia Goodbye" to encourage young women to take action to prevent ... and readily cured with antibiotic treatment. The campaign to " Kiss Chlamydia ...

... , OMAHA, Neb. , Feb. 11 ... dental technology developed to improve human dental health for two ... Cleaning Paste and the Petrodex® Tooth-Hugger Toothbrush. The Petrodex Tooth-Hugger ... Petrodex Ultra Advanced Veterinary Cleaning Paste will be available in ...

... , CINCINNATI , Feb. 11 Kendle (Nasdaq: ... announced the Company has been named to Training magazine,s ... are "unsurpassed in harnessing human capital." Kendle was ranked # 114 ... to be honored in 2010. , "Kendle,s recognition among the Training ...

... , NEW YORK , Feb. 11 ... Security Administration for including early-onset Alzheimer,s disease among the medical ... rather than have individuals go through what could be a ... Alzheimer,s disease," said Eric J. Hall , AFA,s president ...

... a growing trend by the hospital industry to exploit the ... the patient,s expense , BOSTON , ... Center,s East Newton Campus and Tufts Medical Center, who are ... step today of conducting joint informational picketing outside their respective ...

... Feb. 11 The Learning Lab of Brentwood ... Socially , on Thursday February 18 from 12:00-1:30 ... It is the latest in a series of seminars, sponsored by ... and counselors, therapists, and anyone who deals with children or young ...

Cached Medicine News:Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 2 Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 3 Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 4 Health News:College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day 5 Health News:Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeant's Pet Care Products, Inc. 2 Health News:Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeant's Pet Care Products, Inc. 3 Health News:Kendle Named to 'Training Top 125' 2 Health News:Kendle Named to 'Training Top 125' 3 Health News:Alzheimer's Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimer's Disease 2 Health News:Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions 2 Health News:Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions 3 Health News:Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions 4 Health News:Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions 5 Health News:Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions 6 Health News:Learning Lab of Brentwood Leads Free ADHD Seminar 2 Health News:Learning Lab of Brentwood Leads Free ADHD Seminar 3

College Age Females Can 'Kiss Chlamydia Goodbye' for Valentine's Day Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeant's Pet Care Products, Inc.Kendle Named to 'Training Top 125'Alzheimer's Foundation of America Applauds Social Security for Speeding Disability Benefits for Early-Onset Alzheimer's Disease Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions Learning Lab of Brentwood Leads Free ADHD Seminar

Intended for the quantitative determination of magnesium in serum or plasma. Reaction: Endpoint. Wavelength: 520 nm. Linearity: 6.0 mg/dL (2.5 mmol/L)....

For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution....

For the quantitative determination of total glucose in serum....

Glucose reagent is used for the quantitative determination of glucose in human serum....

Medicine Products:

Magnesium Liquid Reagent Magnesium Glucose (Liquid) Reagent Glucose Hexokinase Reagent Set